MyD88−∕− myocytes showed no increase in CaMKII oxidation in response to lipopolysaccharide and were protected against CaMKII oxidation, cardiac hypertrophy, inflammation, apoptosis, and mortality following myocardial infarction (Singh et al., 2012). The gene discussed is CAMK2G; the disease is myocardial infarction.